![Michael Atieh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Atieh
Director/Board Member at CHUBB LIMITED
Net worth: 13 M $ as of 2025-11-29
Profile
Michael G.
Atieh is an Independent Director at Chubb Ltd. since 1990.
Mr. Atieh is an Independent Non-Executive Director at Immatics NV since 2021.
Former roles include Executive Chairman at Eyetech, Inc. from 2009 to 2012; Independent Director at ACE Ltd. from 2012 to 2016; CFO, Treasurer, Director & Executive VP at OSI Pharmaceuticals, Inc. from 2005 to 2008; Director at Clintrak Clinical Labeling Services LLC from 2004 to 2006; Independent Director at electroCore, Inc. from 2021 to 2022; Independent Director at Theravance Biopharma, Inc. from 2014 to 2015; Independent Director at Oyster Point Pharma, Inc. from 2020 to 2023; Treasurer & Vice President-US Human Health at Merck & Co., Inc. from 1999 to 2000; Group President at Dendrite International, Inc. from 2002 to 2004; Senior Vice President at Merck-Medco Managed Care LLC from 1994 to 1998; Chief Financial & Business Officer, Treasurer, EVP at IVERIC bio, Inc. from 2014 to 2016; Audit Manager at Ernst & Young SA from 1975 to 1981; CFO, Group President-Global Business Unit & SVP at Cegedim, Inc. Education includes an undergraduate degree from Upsala College, conferred in 1975.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CHUBB LIMITED 0.01% | 2025-06-15 | 39,474 ( 0.01% ) | 12 M $ | 2025-11-29 |
IMMATICS N.V. 0.07% | 2025-01-30 | 87,188 ( 0.07% ) | 932 040 $ | 2025-11-29 |
Latest news about Michael Atieh
Michael Atieh active positions
| Companies | Position | Start |
|---|---|---|
| CHUBB LIMITED | Director/Board Member | 1989-12-31 |
| IMMATICS N.V. | Director/Board Member | 2020-06-30 |
Former positions of Michael Atieh
| Companies | Position | End |
|---|---|---|
| OYSR POIN | Director/Board Member | 2023-01-02 |
| ELECTROCORE, INC. | Chairman | 2021-09-30 |
| IVERIC BIO, INC. | Director of Finance/CFO | 2016-03-30 |
ACE Ltd.
 ACE Ltd. Operates as a holding company which provides commercial property & casualty insurance, and reinsurance products and services | Director/Board Member | 2016-01-13 |
| THERAVANCE BIOPHARMA, INC. | Director/Board Member | 2015-04-21 |
Training of Michael Atieh
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
ACE Ltd.
ACE Ltd. Operates as a holding company which provides commercial property & casualty insurance, and reinsurance products and services | |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Manufactures and develops pharmaceutical drugs | |
Merck & Co., Inc.
 Merck & Co., Inc. Manufactures human and animal health pharmaceutical products & vaccines | |
Dendrite International, Inc.
 Dendrite International, Inc. Packaged SoftwareTechnology Services Provides sales force software products and support services | Technology Services |
Eyetech, Inc.
 Eyetech, Inc. Provides ophthalmic biotechnology services | |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Clintrak Clinical Labeling Services LLC
 Clintrak Clinical Labeling Services LLC Miscellaneous Commercial ServicesCommercial Services Provides healthcare integration services company that unites health plans and clinical laboratories | Commercial Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology Manufactures and sells gene therapy products to treat diseases of the eye | Health Technology |
Upsala College
 Upsala College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young SA
 Ernst & Young SA Investment ManagersFinance Provides investment advisory services | Finance |
electroCore, Inc.
 electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies | Health Technology |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | |
Cegedim, Inc. | |
Chubb Ltd.
 Chubb Ltd. Operates as a holding company for a family of property and casualty insurance companies | |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Develops and commercializes pharmaceutical therapies to treat ocular surface diseases | |
Immatics NV
 Immatics NV Engages in developing immunotherapies for cancer treatments |
- Stock Market
- Insiders
- Michael Atieh
